Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation

• Published in: Transplantation proceedings 2018-05, Vol.50 (4), p.1087-1093
• Main Authors: Ma, K.W., Chan, A.C.Y., She, B.W.H., Chok, K.S.H., Cheung, T.T., Dai, J.W.C., Fung, J.Y.Y., Lo, C.M.
• Format: Article
• Language: English
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2018.01.025

The objective of this study was to compare the long-term outcomes of primary and salvage liver transplantation for patients with hepatocellular carcinoma (HCC). This was a 10-year retrospective analysis in a tertiary referral center. There were 184 patients recruited (primary liver transplantation [pLT]:salvage liver transplantation [sLT], 143:41). The median follow-up time was 79 months. Operation time was shorter in the pLT group than the sLT group (661 ± 164 minutes vs 754 ± 206 minutes; P = .01) and the blood loss was 3749 mL and 3545 mL for pLT and sLT, respectively (P = .735). The reoperation rate was 5.6% and 4.9%, respectively (P = 1.0). The 5-year overall and disease-free survival rates from the time of transplantation for pLT and sLT were 84.1% versus 70.2% (P = .01) and 82.2% versus 65.8% (P = .01), respectively. The 5-year overall survival rate from the time of primary treatment for sLT was 80.3% (P = .1). Subgroup analysis of sLT showed that young age (50 vs 56 year old; P = .004) was the only factor associated with poor overall survival. Young age (P = .004) and microvascular permeation (P = .008) in the recurrent tumor were associated with HCC recurrence. Young age stands out to be the only independent factor associated with HCC recurrence. sLT is the treatment of choice for patients with recurrent HCC in regions of graft shortage.